1. Home
  2. IVZ vs SNN Comparison

IVZ vs SNN Comparison

Compare IVZ & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invesco Ltd

IVZ

Invesco Ltd

HOLD

Current Price

$25.36

Market Cap

13.1B

Sector

Finance

ML Signal

HOLD

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

HOLD

Current Price

$36.36

Market Cap

14.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVZ
SNN
Founded
1935
1856
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Investment Managers
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1B
14.3B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
IVZ
SNN
Price
$25.36
$36.36
Analyst Decision
Buy
Hold
Analyst Count
15
3
Target Price
$27.47
$35.75
AVG Volume (30 Days)
5.2M
830.4K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
3.33%
2.01%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,314,100,000.00
N/A
Revenue This Year
N/A
$7.68
Revenue Next Year
$5.70
$5.47
P/E Ratio
N/A
$64.97
Revenue Growth
2.98
N/A
52 Week Low
$11.60
$23.91
52 Week High
$29.61
$38.79

Technical Indicators

Market Signals
Indicator
IVZ
SNN
Relative Strength Index (RSI) 40.97 57.33
Support Level $25.12 $36.13
Resistance Level $27.53 $37.26
Average True Range (ATR) 0.96 0.60
MACD -0.08 -0.02
Stochastic Oscillator 24.70 67.63

Price Performance

Historical Comparison
IVZ
SNN

About IVZ Invesco Ltd

Invesco provides investment-management services to retail (70% of managed assets) and institutional (30%) clients. At the end of November 2025, the firm had $2.154 trillion in assets under management spread among its equity (62% of AUM), balanced (3%), fixed-income (20%), alternative investment (6%), and money market (9%) operations. Passive products account for close to half of Invesco's total AUM. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 31% of its AUM sourced from Europe, Africa, and the Middle East (16%) and Asia (15%).

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: